LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
8.63
-0.39 (-4.32%)
At close: Jun 3, 2026, 4:00 PM EDT
8.80
+0.17 (1.97%)
After-hours: Jun 3, 2026, 4:54 PM EDT
LeonaBio Market Cap
LeonaBio has a market cap or net worth of $81.07 million as of June 3, 2026. Its market cap has increased by 663.37% in one year.
Market Cap
81.07M
Enterprise Value
14.08M
1-Year Change
663.37%
Ranking
Category
Stock Price
$8.63
Market Cap Chart
Since September 18, 2020, LeonaBio's market cap has decreased from $527.32M to $81.07M, a decrease of -84.63%. That is a compound annual growth rate of -27.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 84.73M | 183.80% |
| Dec 31, 2025 | 29.86M | 31.60% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anixa Biosciences | 90.53M |
| OKYO Pharma | 89.74M |
| Rani Therapeutics Holdings | 89.40M |
| Rallybio | 89.24M |
| Atara Biotherapeutics | 87.51M |
| ImmuCell | 87.48M |
| Aardvark Therapeutics | 87.05M |
| MindWalk Holdings | 86.42M |